8-K: ENDI Corp. to Deregister from SEC and Transfer Trading to OTC Pink Market
Current Report
ENDI Corp. announces its intention to deregister its Class A common stock with the SEC and move trading to the OTC Pink market.
Summary
- ENDI Corp. has announced its plan to deregister its Class A common stock from the Securities Exchange Act of 1934.
- The company intends to file a Form 15 with the SEC on or around January 12, 2024, which will suspend their obligation to file regular reports.
- The deregistration is expected to be effective 90 days after the Form 15 filing, terminating the registration of the Class A common stock under Section 12(g) of the Exchange Act.
- Trading of ENDI's Class A common stock is expected to move from the OTCQB venture market to the OTC Pink market.
- The company plans to continue providing information to stockholders and facilitate trading on the OTC Pink market.
- The decision to deregister was made after considering the limited number of stockholders, low trading volume, and the potential for reduced operating expenses.
- ENDI Corp. still intends to file its Form 10-K annual report for the fiscal year ended December 31, 2023.
Sentiment
Score: 5
Explanation: The sentiment is neutral. While the company is taking steps to reduce costs, the move to the OTC Pink market and deregistration could be seen as a negative by some investors. The company is still intending to file its 10K which is a positive.
Positives
- The company expects to reduce operating expenses by eliminating SEC reporting costs and reducing audit expenses.
- ENDI intends to continue providing information to its stockholders and facilitate trading on the OTC Pink market.
- The company believes that the OTC Pink market will provide a substantially equivalent trading opportunity for its stockholders.
Negatives
- There is no guarantee that a broker will continue to make a market in the Class A common stock.
- There is no guarantee that trading of the Class A common stock will continue on the OTC Pink or otherwise.
- The company will no longer be required to file regular reports with the SEC after deregistration.
Risks
- The deregistration process and transfer to the OTC Pink market could impact the liquidity and trading volume of the stock.
- There is a risk that a broker may not continue to make a market for the stock on the OTC Pink market.
- The company's decision to deregister could be perceived negatively by some investors.
- The company's forward-looking statements are subject to various risks and uncertainties.
Future Outlook
The company intends to continue providing information to its stockholders and to take such actions within its control to enable its Class A common stock to be quoted on the OTC Pink, so that a trading market may continue to exist for its Class A common stock. However, there is no guarantee that a broker will continue to make a market in the Class A common stock and that trading of the Class A common stock will continue on the OTC Pink or otherwise.
Management Comments
- The company made the decision to pursue deregistration following the careful review and consideration by its Board of a number of factors.
- The company anticipates that as a result of deregistration, trading in the Company's Class A common stock will transfer from the OTCQB to the OTC Pink market.
Industry Context
Companies sometimes choose to deregister from the SEC to reduce costs and regulatory burdens, especially if they have limited trading volume or a small number of shareholders. This move is not uncommon for smaller companies that find the costs of SEC compliance outweigh the benefits.
Comparison to Industry Standards
- Deregistering from the SEC and moving to the OTC Pink market is a strategy sometimes employed by smaller companies to reduce compliance costs, similar to companies like some micro-cap or penny stock firms that have limited trading volume.
- The move to the OTC Pink market is a step down from the OTCQB, which is a more regulated market, and is similar to other companies that have chosen to reduce their regulatory burden.
- The decision to deregister is often driven by a cost-benefit analysis, where the costs of SEC compliance are weighed against the benefits of being a publicly traded company, a decision that is common among smaller companies with limited trading activity.
Stakeholder Impact
- Shareholders may experience changes in the liquidity and trading of their shares.
- Employees may be impacted by the company's cost-cutting measures.
- Customers and suppliers may not be directly impacted by this announcement.
Next Steps
- The company will file a Form 15 with the SEC on or about January 12, 2024.
- The company will transfer trading of its Class A common stock to the OTC Pink market.
- The company will continue to provide information to its stockholders.
- The company will file its Form 10-K annual report for the fiscal year ended December 31, 2023.
Key Dates
| Date | Description |
|---|---|
| 2021-12-29 | Date of the original Agreement and Plan of Merger. |
| 2022-08-11 | Date of the business combination with Enterprise Diversified, Inc. and CrossingBridge Advisors, LLC and the original Registration Rights Agreement. |
| 2023-12-31 | The Outside Date, after which the company could terminate the offerings and deregister unsold securities under the Form S-4. |
| 2024-01-12 | Date of the third amendment to the Merger Agreement, the fourth amendment to the Registration Rights Agreement, and the press release announcing the deregistration and transfer to the OTC Pink market. |
Keywords
deregistration, OTC Pink, Form 15, SEC, trading, common stock, reporting obligations, operating expenses, OTCQB
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.